IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 138 filers reported holding IMMUNOCORE HLDGS PLC in Q4 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,201,980 | -13.4% | 80,963 | 0.0% | 1.29% | +50.9% |
| Q2 2023 | $4,854,541 | +21.3% | 80,963 | 0.0% | 0.85% | +3.0% |
| Q1 2023 | $4,002,811 | -13.4% | 80,963 | 0.0% | 0.83% | -16.8% |
| Q4 2022 | $4,620,558 | +21.6% | 80,963 | 0.0% | 0.99% | +12.2% |
| Q3 2022 | $3,800,000 | -36.7% | 80,963 | -49.7% | 0.89% | -44.7% |
| Q2 2022 | $6,006,000 | +24.8% | 160,963 | 0.0% | 1.60% | +32.1% |
| Q1 2022 | $4,813,000 | +119.7% | 160,963 | +151.5% | 1.21% | +185.2% |
| Q4 2021 | $2,191,000 | -7.6% | 64,000 | 0.0% | 0.42% | +14.2% |
| Q3 2021 | $2,372,000 | -5.1% | 64,000 | 0.0% | 0.37% | +20.8% |
| Q2 2021 | $2,499,000 | -26.6% | 64,000 | -20.0% | 0.31% | -51.0% |
| Q1 2021 | $3,406,000 | – | 80,000 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $34,592,303 | 27.53% |
| RTW INVESTMENTS, LP | 6,029,633 | $361,536,795 | 6.88% |
| Paradigm Biocapital Advisors LP | 1,270,124 | $76,156,635 | 5.88% |
| Rock Springs Capital Management LP | 3,028,410 | $181,583,464 | 4.32% |
| Logos Global Management LP | 500,000 | $29,980,000 | 4.08% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $24,319,776 | 3.58% |
| GREAT POINT PARTNERS LLC | 297,082 | $17,813,037 | 3.49% |
| Eschler Asset Management LLP | 34,000 | $2,038,640 | 2.89% |
| COWEN AND COMPANY, LLC | 460,036 | $27,583,758 | 2.29% |
| HighVista Strategies LLC | 44,094 | $2,643,876 | 1.21% |